CrushSCI.com
Journal Selection & Manuscript Polishing Services
EUROPEAN JOURNAL OF HUMAN GENETICS journal cover Biology
Back to journal directory

Review Cycle Records

EUROPEAN JOURNAL OF HUMAN GENETICS

Springer SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
179.1Average days
158.5Median days
14Fastest days
315Longest days
2212025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

14 days

Clinical implementation of polygenic risk scores—updates on ancestry-adjusted PRS and their use in practice

AuthorsEleanor Roberts; Nicola Flaum; D. Gareth Evans

Affiliations1. Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 2. Manchester Breast Centre, The Christie, Manchester, UK; 3. Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester Academic Health Centre (MAHSC), Division of Evolution, Infection and Genomic Sciences, University of Manchester, Manchester, UK; 4. Prevent Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Trust, Manchester, UK; 5. Manchester Centre for Genomic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK

Source PDF DOI Publisher page
99 days

Re: Clinical implementation of polygenic risk scores — equity metrics are needed before clinical translation

AuthorsLaura Piñero-Roig

Affiliations1. MD Student, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain

Source PDF DOI Publisher page
257 days

Bridging the gap: integrating hereditary cancer into precision oncology

AuthorsAlejandra Rezqallah; Mara Cruellas; Judith Balmaña

Affiliations1. Hereditary Cancer Genetics Group, Medical Oncology Department, University Hospital Vall d’Hebron and Vall d’Hebron Institute of Oncology, Barcelona, Spain; 2. Hereditary Cancer Unit, Medical Oncology Department, University Hospital Lozano Blesa / Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain

Source PDF DOI Publisher page
189 days

CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders

AuthorsMatthias De Wachter; Mathijs B. van der Lei; Amber Decleve; Kevin De Man; Ellen Elinck; An-Sofie Schoonjans; Evan Gouy; Louis Januel; Pauline Monin; Audrey Labalme; Amelle Shillington; Himanshu Goel; Juliet P. Taylor; Katherine Neas; David A. Koolen; Francois Lecoquierre; Alice Goldenberg; Theresa Brunet; Melanie Brugger; Minjie Luo; Magdalena Krygier; Maria Mazurkiewicz-Bełdzińska; Manon Degoutin; Claire Beneteau; Cyril Goizet; David D. Weaver; Emily G. Farrow; Angela Lee; Randi N. Gadea; Berten Ceulemans; Peter A. M. de Witte; Daniëlle Copmans; Anna C. Jansen; R. Frank Kooy

Affiliations1. Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium; 2. Department of Medical Genetics, University of Antwerp, Antwerp, Belgium; 3. Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; 4. Leuven Childhood Epilepsy Center, Leuven Brain Institute, KU Leuven, UZ Leuven, Leuven, Belgium; 5. Research on Healthcare Performance Reshape, INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France; 6. Hospices Civils de Lyon, Service de Génétique, Lyon, France; 7. Cincinnati Children’s Medical Center, Cincinnati, USA; 8. School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; 9. Genetic Health Service NZ (North), Auckland, New Zealand; 10. Genetic Health Service NZ, Wellington South, New Zealand; 11. Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands; 12. Hospitalo-Universitaire, CHU de Rouen, Rouen, France; 13. Institute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich, Germany; 14. Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, USA; 15. Department of Pathology and Laboratory Medicine, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; 16. Department of Developmental Neurology, Medical University of Gdańsk, Gdańsk, Poland; 17. CHU Bordeaux, Service de Génétique Médicale, Bordeaux, France; 18. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, USA; 19. Clinical Genetics and Genomics Laboratory, Pathology and Laboratory Medicine, Children’s Mercy Kansas City, Kansas City, USA; 20. Department of Translational Neurosciences, University of Antwerp, Antwerp, Belgium

Source PDF DOI Publisher page
118 days

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta

AuthorsBikiran Behera; Charlotta Ingvoldstad Malmgren; Eva Åström; Lyn S. Chitty; Belinda Crowe; Anna L. David; Catherine DeVile; Oliver Semler; Magnus Westgren; Cecilia Götherström; Melissa Hill

Affiliations1. BSc Paediatrics and Child Health, UCL Great Ormond Street Institute of Child Health, London, UK; 2. Center for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden; 3. Center for Fetal Medicine, Karolinska University Hospital, Stockholm, Sweden; 4. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; 5. Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; 6. Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; 7. North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 8. Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; 9. Department of Neurosciences, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 10. Elizabeth Garrett Anderson Institute for Women’s Health, University College London, London, UK; 11. NIHR University College London Hospitals Biomedical Research Centre, London, UK; 12. Department of Pediatrics, University Hospital Cologne, Koln, Germany; 13. Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; 14. Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden

Source PDF DOI Publisher page
127 days

Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders

AuthorsAnkur Chaurasia; Anju Shukla; Shruti Pande; Greeshma Purushothama; Akhil Kanathay Ashokan; Purvi Majethia; Namanpreet Kaur; Priyanka Upadhyai; Neha Quadri; Gandham SriLakshmi Bhavani; Dhanya Lakshmi Narayanan; Shalini S. Nayak; Sheela Nampoothiri; Ataf H. Sabir; Alaa A. Mohammed; Sophie Shaw; Verity L. Hartill; Christopher M. Watson; Colin A. Johnson; Afrah Alshammari; Andrew E. Fry; James A. Poulter; William G. Newman; Paul R. Kasher; Siddharth Banka; Katta M. Girisha

Affiliations1. Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India; 2. Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 3. Department of Paediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, Cochin, India; 4. West Midlands Clinical Genetics Unit, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK; 5. Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK; 6. West Midlands Genomics Laboratory, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK; 7. All Wales Medical Genomics Service, Wales Genomic Health Centre, Cardiff, UK; 8. Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; 9. Leeds Clinical Genomics Service, Chapel Allerton Hospital, Leeds, UK; 10. Yorkshire and North East Genomic Laboratory Hub, Central Lab, St. James’s University Hospital, Leeds, UK; 11. Department of Biology, College of Science, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia; 12. Division of Cancer and Genetics, Cardiff University, Cardiff, UK; 13. Manchester Centre for Genomic Medicine, St Mary’s Hospital, Health Innovation Manchester, Manchester University NHS Foundation Trust, Manchester, UK; 14. Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK; 15. Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust and University of Manchester, Manchester, UK; 16. Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Source PDF DOI Publisher page
128 days

Decoding splicing variants in high-throughput sequencing: a functional validation approach integrating deep learning tools

AuthorsClément Hersent; Lise Larrieu; Patricia Fergelot; Julie Miro; Mehdi Benkirane; Chloé Angelini; Francis Ramond; Cecilia Marelli; Isabelle Sabatier; Gaëtan Lesca; Christel Vaché; Mireille Cossée; Anne Bergougnoux; Klaus Dieterich; Christine Tranchant; Isabelle Marey; Anna Castrioto; Christel Thauvin-Robinet; Lydia Abou Haidar; François Rivier; Sylvie Tuffery-Giraud; Michel Koenig

Affiliations1. Laboratoire de Génétique Moléculaire de Maladies Rares, Site Unique de Biologie, CHU de Montpellier, Montpellier, France; 2. PhyMedExp, Univ Montpellier, CNRS, INSERM, Montpellier, France; 3. Neurogenetics Reference Centre, Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France; 4. Department of Medical Genetics, Laboratory of Genomics Medicine, Sorbonne University, Hôpital de la Pitié-Salpêtrière, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France; 5. Department of Medical Genetics, CHU of Saint-Etienne, Saint-Etienne, France; 6. MMDN, Université de Montpellier, EPHE, INSERM, Montpellier, France; 7. Expert Center for Neurogenetic Diseases, CHU de Montpellier, Montpellier, France; 8. Department of Pediatric Neurology, University Hospitals of Lyon, Lyon, France; 9. Department of Medical Genetics, University Hospitals of Lyon and Université Claude Bernard Lyon1, Lyon, France; 10. Department of Medical Genetics, CHU de Grenoble, Grenoble, Université Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France; 11. Department of Neurology, Hôpitaux Universitaires de Strasbourg, Strasbourg; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; 12. Grenoble Institute of Neurosciences, Grenoble Alpes University Hospital Center, Inserm, U1216, Grenoble Alpes University, Grenoble, France; 13. Université de Bourgogne Europe, CHU Dijon Bourgogne, Centre de Génétique, Centre de Référence Maladies Rares Neurogène, INSERM, CTM UMR 1231, GAD, Dijon, France; 14. Department of Pediatric Neurology and Reference Center for Neuromuscular Diseases AOC, Gui de Chauliac Hospital, CHU de Montpellier, Montpellier, France

Source PDF DOI Publisher page
301 days

Hemizygous loss-of-function variants of EIF1AX are associated with a syndromic neurodevelopmental disorder

AuthorsKazuyuki Komatsu; Atsushi Sugie; Yohei Nitta; Jiro Osaka; Ummul Halilunnisa Mansoor Hussain; Mitsuru Kubota; Nobuyuki Shimozawa; Melissa T. Carter; Petra J. G. Zwijnenburg; Quinten Waisfisz; Felix Boschann; Denise Horn; Mitsuko Nakashima; Hirotomo Saitsu

Affiliations1. Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan; 2. Brain Research Institute, Niigata University, Niigata, Japan; 3. Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan; 4. Division of Genomics Research, Life Science Research Center, Gifu University, Gifu, Japan; 5. Department of Genetics, Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada; 6. Department of Clinical Genetics, Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; 7. Institute of Medical Genetics and Human Genetics, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 8. Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany; 9. Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany

Source PDF DOI Publisher page
243 days

Identifying genetic causes and establishing a diagnostic approach for WES-negative pediatric population with neurodevelopmental disorder

AuthorsYeseul Kim; Joowon Jang; Kyeong Seon Ryu; Jong-Hee Chae; Jung Min Ko; Man Jin Kim; Seungbok Lee; Jangsup Moon; Jin Sook Lee; Hoyeon Lee; Sung Im Cho; Seung Won Chae; Hansol Lim; Hara Lim; Hobin Sung; Seonhoo Youn; Hyesu Lee; Jee-Soo Lee; Moon-Woo Seong

Affiliations1. Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; 2. Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea; 3. Department of Pediatrics, Seoul National University Children’s Hospital, Seoul, Korea; 4. Department of Neurology, Seoul National University Hospital, Seoul, Korea; 5. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

Source PDF DOI Publisher page
315 days

Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival

AuthorsWeijia Fu; Joseph H. Rothstein; Olle Melander; Hans Lilja; Weiva Sieh; Xiaoyu Song; Robert J. Klein

Affiliations1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 2. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA; 3. Department of Epidemiology, MD Anderson Cancer Center, Houston, USA; 4. Department of Clinical Sciences, Lund University, Malmö, Sweden; 5. Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden; 6. Departments of Pathology and Laboratory Medicine, Surgery (Urology Service), and Medicine (GU-Oncology Service), Memorial Sloan Kettering Cancer Center, New York, USA; 7. Department of Translational Medicine, Lund University, Malmö, Sweden; 8. Centre for Biomedical Data Science, Duke-NUS Medical School, National University of, Singapore, Singapore

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.